EFX vs XRAY · P/E 54, rev $5.68B vs rev $3.68B
Equifax Inc (EFX) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Equifax Inc (EFX) is a consulting services company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported EFX revenue for 2024-12-31 was $5.68B. Net income was $607.3M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Latest reported XRAY revenue for 2025-12-31 was $3.68B. Net income was -$598.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. XRAY currently screens at market cap $2.01B.
EFX currently screens at market cap $33.00B and trailing P/E 54.0. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the EFX and XRAY stock pages for the full models.
Not investment advice.